{Reference Type}: Journal Article
{Title}: Glucose disturbances in very low-birthweight infants-Results from the prospective LIGHT study.
{Author}: Zamir I;Stoltz Sjöström E;van den Berg J;Berhan Y;Naumburg E;Domellöf M;
{Journal}: Acta Paediatr
{Volume}: 0
{Issue}: 0
{Year}: 2024 Aug 1
{Factor}: 4.056
{DOI}: 10.1111/apa.17370
{Abstract}: <B>OBJECTIVE: </B>To describe glucose homeostasis disturbances (dysglycaemia) in very low-birthweight infants (<1500 g) during the admission period and explore associated risk factors.<BR><B>METHODS: </B>The LIGHT (very low-birthweight infants - glucose and hormonal profile over time) study was a prospective observational cohort study that included 49 very low-birthweight infants admitted to the tertiary neonatal intensive care unit in Umeå, Sweden, during 2016-2019. All glucose concentrations (n = 3515) sampled during the admission period were registered.<BR><B>RESULTS: </B>Hyperglycaemia >10 mmol/L and hypoglycaemia <2.6 mmol/L were registered in 63% and 55% of the infants, respectively. Onset of dysglycaemia occurred almost exclusively in the first postnatal week. Hyperglycaemia followed 15% of corticosteroid doses given; all were preceded by pre-existing hyperglycaemia. Pre-existing hyperglycaemia was found in 66.7% of hyperglycaemic infants who received inotrope treatment. Upon commencement, 72.5% of antimicrobial treatments given were neither preceded nor followed by hyperglycaemia.<BR><B>CONCLUSIONS: </B>Dysglycaemia was common in very low-birthweight infants. Daily means of glucose concentrations seemed to follow a postmenstrual age-dependent pattern, decreasing towards term age suggesting a postmenstrual age-dependent developmental mechanism. The primary mechanism causing hyperglycaemia was independent of sepsis, and corticosteroid and inotrope treatments. No hypoglycaemia was registered during ongoing insulin treatment.